Exponent, Inc. (EXPO) Income Statement

The 20.9% growth in 2026Q2 marks a significant inflection from the near-flat growth in 2025Q2, indicating that the firm is capturing increased demand, possibly from complex failure analysis and proactive risk consulting. However, given the lumpy nature of litigation-driven projects, investors should monitor whether this acceleration is sustainable or a function of timing. The raised full-year guidance supports a positive outlook, but the quarterly volatility warrants caution.

The reported gross margin is distorted by reimbursable expenses, which are pass-through costs with no margin. When focusing on revenues before reimbursements, the gross margin likely remains in the high-20s to low-30s range, consistent with historical levels. This suggests that the firm's pricing power and cost structure are stable, but the volatility in reported margins can mislead. The competitive market for PhD-level talent may pressure margins over time, but current data does not show a clear deterioration.

SG&A expenses remained relatively flat at $7.4M in 2026Q2 versus $6.1M in 2025Q2, while revenue grew significantly, leading to a 4.2 percentage point expansion in operating margin. This suggests that the firm is scaling revenue without proportional increases in overhead, a sign of effective cost control. However, the sustainability of this leverage depends on maintaining high utilization rates and controlling compensation costs, which are the primary variable expenses.

The fact that COGS grew slower than revenue suggests that the firm is managing its billable headcount and utilization effectively, allowing for margin expansion. However, the intense competition for PhD-level STEM talent from Big Tech and AI startups poses a risk to this cost discipline. If wage inflation accelerates, gross margins could compress, as the firm may not be able to pass through higher costs immediately. Monitoring the realized hourly rate and utilization will be critical.